# Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

> **NCT00663273** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 30 (actual)

## Conditions studied

- Hygiene

## Interventions

- **DRUG:** Lactic acid (Dermacid)

## Key facts

- **NCT ID:** NCT00663273
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-01
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2009-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663273, "Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00663273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*